gategroup Holding AG ( "gategroup" ) is pleased to announce the successful pricing of its comprehensive refinancing package, comprising two term loans of EUR 675 million and USD 500 million, both with a tenure of 7 years, and a CHF 300 million multicurrency revolving credit facility ( the "new ...

BISMARCK, N.D., May 28, 2025 /PRNewswire/ -- North Dakota is where the spirit of the American West lives on in rodeo arenas, historic villages, and across windswept prairies.

gategroup Holding AG ( "gategroup" ) is pleased to announce the successful pricing of its comprehensive refinancing package, comprising two term loans of EUR 675 million and USD 500 million, both with a tenure of 7 years, and a CHF 300 million multicurrency revolving credit facility ( the "new ...

President Trump's pro-crypto push continues, with his Department of Labor reversing course on 2022 guidance against crypto in 401(k) plans.

Analyst says functional drinks like protein, probiotics, and zero sugar are driving value as volume stays flat across beverages. Coca-Cola, KDP, BRBR, and CCEP all retain Buy ratings, backed by brand strength, growth potential, and category tailwinds.

IBM's IBM short percent of float has risen 3.66% since its last report. The company recently reported that it has 21.31 million shares sold short, which is 2.55% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.64 days to cover their short ...

In the current session, the stock is trading at $25.99, after a 1.17% increase. Over the past month, Byrna Technologies Inc. BYRN stock increased by 15.32%, and in the past year, by 113.21%.

Freely explore the lands of Midgard and join a series of events to celebrate this milestone SÃO PAULO, Brazil, May 28, 2025 /PRNewswire/ -- The moment fans have been eagerly waiting for has finally arrived.

SEATTLE, May 28, 2025 ( GLOBE NEWSWIRE ) -- Adaptive Biotechnologies Corporation ( Nasdaq: ADPT ) , a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be ...

SEATTLE, May 28, 2025 ( GLOBE NEWSWIRE ) -- Sana Biotechnology, Inc. ( NASDAQ: SANA ) , a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in June.